Link Pharma Chem Limited
BSE:524748
Cash Flow Statement
Cash Flow Statement
Link Pharma Chem Limited
| Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||
| Net Income |
14
|
19
|
17
|
22
|
26
|
21
|
9
|
(25)
|
(19)
|
6
|
(14)
|
(9)
|
|
| Depreciation & Amortization |
9
|
9
|
9
|
8
|
9
|
9
|
9
|
10
|
10
|
10
|
9
|
10
|
|
| Other Non-Cash Items |
11
|
7
|
6
|
5
|
0
|
5
|
13
|
8
|
3
|
1
|
6
|
9
|
|
| Cash Taxes Paid |
(1)
|
0
|
5
|
3
|
7
|
9
|
4
|
4
|
4
|
2
|
(0)
|
(0)
|
|
| Cash Interest Paid |
4
|
4
|
4
|
5
|
5
|
5
|
8
|
9
|
9
|
9
|
8
|
6
|
|
| Change in Working Capital |
(5)
|
13
|
17
|
(56)
|
(48)
|
(10)
|
(48)
|
(0)
|
6
|
(2)
|
26
|
2
|
|
| Cash from Operating Activities |
30
N/A
|
48
+62%
|
49
+2%
|
(21)
N/A
|
(13)
+41%
|
25
N/A
|
(17)
N/A
|
(7)
+58%
|
(0)
+96%
|
14
N/A
|
27
+89%
|
12
-56%
|
|
| Investing Cash Flow | |||||||||||||
| Capital Expenditures |
(17)
|
(13)
|
(18)
|
(19)
|
(12)
|
(11)
|
(9)
|
(7)
|
(10)
|
(8)
|
(3)
|
(14)
|
|
| Other Items |
1
|
1
|
(4)
|
0
|
(38)
|
(56)
|
8
|
35
|
14
|
(0)
|
18
|
13
|
|
| Cash from Investing Activities |
(17)
N/A
|
(12)
+27%
|
(22)
-80%
|
(19)
+12%
|
(50)
-160%
|
(67)
-35%
|
(1)
+99%
|
28
N/A
|
4
-86%
|
(9)
N/A
|
15
N/A
|
(0)
N/A
|
|
| Financing Cash Flow | |||||||||||||
| Net Issuance of Debt |
9
|
22
|
1
|
1
|
27
|
38
|
24
|
8
|
5
|
(7)
|
(34)
|
(1)
|
|
| Other |
(4)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(8)
|
(9)
|
(9)
|
(9)
|
(8)
|
(6)
|
|
| Cash from Financing Activities |
6
N/A
|
18
+226%
|
(3)
N/A
|
(4)
-23%
|
23
N/A
|
33
+44%
|
16
-51%
|
(1)
N/A
|
(4)
-344%
|
(16)
-284%
|
(42)
-170%
|
(7)
+84%
|
|
| Change in Cash | |||||||||||||
| Net Change in Cash |
18
N/A
|
54
+191%
|
24
-56%
|
(45)
N/A
|
(40)
+11%
|
(9)
+77%
|
(2)
+81%
|
20
N/A
|
(0)
N/A
|
(10)
-3 264%
|
0
N/A
|
5
+157 000%
|
|
| Free Cash Flow | |||||||||||||
| Free Cash Flow |
12
N/A
|
35
+183%
|
30
-13%
|
(40)
N/A
|
(24)
+41%
|
14
N/A
|
(26)
N/A
|
(14)
+46%
|
(10)
+30%
|
6
N/A
|
24
+299%
|
(2)
N/A
|
|